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Abstract
Objective: To evaluate the role of hospitals in DKI Jakarta on pri-
mary and secondary cervical cancer prevention.
Method: This was a survey conducted to 25 hospitals, chosen with
simple random sampling from 109 hospitals in DKI Jakarta. Ques-
tionnaire used for interview contained statements regarding know-
ledge, attitude and behavior of 117 health care professionals along
with identification of facility preparedness for cervical cancer pre-
vention within those 25 hospitals.
Result: The assessment of knowledge shows that all health care pro-
fessionals (100%) knew that HPV vaccination is used as a primary
prevention for cervical cancer. About 98.3% respondent knew HPV
vaccine injected intramuscularly. As much as 91.5% of the respon-
dent knew HPV vaccine is given three times either at month 0, 1, 6
or at month 0, 2, 6. About 71.8% respondent knew deltoid as site for
vaccine injection.
Most of health care professionals (99.1%) knew VIA (visual inspec-
tion with acetic acid) can be used for early detection of cervical can-
cer. About 76.9% respondent knew how to interpret positive VIA re-
sults and 60.7% respondent knew how to do VIA test. As much as
93.2% health care professional knew the purpose of Pap test and
about 82.1% knew how to do it. From attitude aspect, most of health
care professionals (96.6%) agreed in giving HPV vaccination. About
94% of them agreed to do VIA test and about 98.3% agreed in con-
ducting Pap test. From behavioral aspect, most of the respondent
(76.9%) offered HPV vaccination to their clients/patients and 62.4%
respondent did HPV vaccination. VIA test was offered and conducted
by 52.1% and 30.8% of them, respectively. About 86.3% respondent
offered Pap test and 71.8% did the Pap test. As many as 75% of fe-
male health care professionals who meet the qualification already
had a Pap test for themselves, but only 32.5% ever been vaccinated
for HPV.
From facility aspect, twenty hospitals (80%) in DKI Jakarta offered
HPV vaccination with Pap test can be done in all of them. VIA test
and colposcopy were only available in eleven (44%) and ten (40%)
hospitals respectively.
Conclusion: Most hospitals in DKI Jakarta have health care profes-
sionals with good knowledge and attitude in cervical cancer preven-
tion. However, not many have shown expected behavior in the pri-
mary prevention. Most hospitals in DKI Jakarta provide facilities for
HPV vaccination and Pap test, but only few have VIA facilities and
colposcopy.
[Indones J Obstet Gynecol 2014; 2-1: 3-9]
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Abstrak
Tujuan: Mengetahui peran rumah sakit di DKI Jakarta dalam pence-
gahan primer dan sekunder kanker serviks.
Metode: Penelitian ini adalah survei yang dilakukan pada 25 rumah
sakit yang dipilih secara simple random sampling dari 109 rumah
sakit yang ada di DKI Jakarta. Dilakukan wawancara menggunakan
kuesioner yang berisi pertanyaan mengenai aspek pengetahuan, sikap
dan perilaku terhadap 117 tenaga kesehatan serta identifikasi kesiap-
an fasilitas terkait pencegahan kanker serviks pada 25 rumah sakit
tersebut.
Hasil: Dari aspek pengetahuan penelitian ini menunjukkan bahwa se-
mua tenaga kesehatan (100%) mengetahui bahwa vaksinasi HPV di-
lakukan sebagai pencegahan primer kanker serviks, 98,3% mengeta-
hui bahwa vaksin HPV disuntikkan intra muskular, 91,5% mengetahui
bahwa vaksinasi HPV diberikan 3x yaitu pada bulan ke 0, 1, 6 atau 0,
2, 6, dan 71,8% mengetahui bahwa vaksin HPV disuntikkan pada del-
toid.
Sebagian besar tenaga kesehatan (99,1%) mengetahui bahwa tes IVA
(Inspeksi Visual dengan Aplikasi Asam Asetat) dapat digunakan untuk
deteksi dini kanker serviks, 76,9% mengetahui cara menginterpretasi
hasil tes IVA yang positif, dan 60,7% tahu bagaimana cara melakukan
tes IVA. Sebanyak 93,2% tenaga kesehatan mengetahui tujuan tes pap
dan 82,1% mengetahui bagaimana cara melakukan tes pap. Dari as-
pek sikap, sebagian besar tenaga kesehatan (96,6%) setuju untuk
memberikan vaksinasi HPV, 94% setuju untuk melakukan tes IVA dan
98,3% setuju untuk melakukan tes pap. Dari aspek perilaku, sebagian
besar tenaga kesehatan (76,9%) menawarkan pada klien/pasiennya
vaksinasi HPV dan 62,4% pernah melakukan vaksinasi HPV, 52,1%
menawarkan dan 30,8% pernah melakukan pemeriksaan IVA serta
86,3% menawarkan dan 71,8% melakukan tes pap. Sebagian besar
tenaga kesehatan perempuan yang sesuai dengan persyaratan (75%)
sudah melakukan tes pap bagi dirinya sendiri, tetapi hanya 32,5%
yang sudah mendapatkan vaksinasi HPV.
Dari segi fasilitas, 20 rumah sakit (80%) di DKI Jakarta menyediakan
vaksinasi HPV, dan semua (100%) rumah sakit menyediakan tes pap.
Hanya 11 rumah sakit (44%) yang menyediakan tes IVA dan 10 ru-
mah sakit (40%) yang menyediakan kolposkopi.
Kesimpulan: Sebagian besar rumah sakit di DKI Jakarta sudah mem-
punyai tenaga kesehatan dengan pengetahuan dan sikap yang baik
dalam pencegahan kanker serviks, namun dari aspek perilaku se-
bagian besar belum menunjukkan perilaku yang baik dalam pence-
gahan primer kanker serviks. Sebagian besar rumah sakit di DKI
Jakarta sudah menyediakan fasilitas pelayanan vaksinasi HPV dan tes
pap, namun sebagian besar belum menyediakan fasilitas IVA dan
kolposkopi.
[Maj Obstet Ginekol Indones 2014; 2-1: 3-9]
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INTRODUCTION
Cervical cancer is the number two cancer most
often found in women worldwide,1-5 and is the
number two cause of death caused by cancer.6-8
Based on data from GLOBOCAN 2002, Indonesia
ranks as the second highest in the world after
China for cervical cancer cases. As many as 15,050
cases was found with 7566 deaths. Every day, it is
estimated that there are 41 new cases of cervical
cancer and 20 women died due to cervical cancer.7
The mortality remains high since 90% of cases di-
agnosed at an advanced stage.9
The problems caused by cervical cancer become
tremendous, therefore the cervical cancer preven-
tion, since cervical cancer can be prevented,3,10
should be done thoroughly and integrated. There
are three ways to prevent cervical cancer, ie pri-
mary prevention, secondary, and tertiary. Primary
prevention can be done by giving an education of
the risk factors and getting HPV vaccination, sec-
ondary prevention can be done by cervical cancer
screening and proper treatment for positive
screening result cases, while tertiary prevention is
done by treating cervical cancer as early as possi-
ble to avoid the complications.
Hospital has an important role in the prevention
of cervical cancer, both in primary prevention (HPV
vaccination) and secondary prevention (screening
and treatment of positive screening result). If the
role can be run well by most hospitals in Indonesia,
the incidence and morbidity due to cervical cancer
can be decreased. Unfortunately, there has been no
research conducted on the hospital’s role in the
prevention of cervical cancer. Therefore, research
is needed to determine the role of hospitals in the
cervical cancer prevention.
The objective of this study is to determine the
readiness of health workers (knowledge, attitude
and behavior of midwives, general practitioners
(GPs) and obstetricians) in hospital in Jakarta in
primary and secondary prevention of cervical can-
cer, determine the readiness of hospital facilities in
Jakarta in HPV vaccination services, determine
readiness of hospital facilities in Jakarta in cervical
cancer screening services, particularly the VIA test,
Pap test and HPV tests, as well as knowing the
readiness of hospital facilities in Jakarta in deliver-
ing cases with a positive screening result.
METHOD
This study is a survey conducted in 25 hospitals
selected by simple random sampling of 109 hospi-
tals in Jakarta, both private and government, from
March 2012 until July 2012.
At each hospital selected, set 7 respondents in
each hospital, consist of 1 managerial member, 2
obstetricians, 2 general practitioners and 2 mid-
wives working in the polyclinic. Interviews were
conducted using a questionnaire about aspects of
knowledge, attitudes and behaviors of health
workers on primary and secondary prevention of
cervical cancer, instead of observation made in the
polyclinic where they work. Observations were
also carried out in the waiting room. The data col-
lection was also performed at pharmacies and pa-
thology anatomy. Data processing was performed
using SPSS (Statistic Program for Social Status).
RESULT
By the simple random sampling, 25 of 109 hospi-
tals were chosen. There were 8 government hos-
pitals and 17 private hospitals (3 type A hospitals,
6 type B hospitals and 16 type C hospitals), have
been studied. There were eight hospitals which all
of the proposed health care workers completely in-
terviewed. Unfortunately only less than 6 workers
were interviewed in 3 hospitals that have complete
proposed health care worker since the respondent
was difficult to interview. In 14 hospitals, general
practitioners were not interviewed since they did
not work in the polyclinic.
A total of 117 health workers were interviewed,
consists of 49 (42%) midwives, 21 (18%) general
practitioners, and 47 (40%) obstetricians. Most of
respondents (69%) were female. Thirty seven peo-
ple are the lecturer (32%).
The most frequent attended course was the Pap
test, followed by 59% health workers. HPV test
was the least attended course, only 35.9% of the
subjects. Obstetricians were always of the highest
percentages in course attending. The general prac-
titioners held the lowest attendance. They also held
the lowest attendance in HPV test and VIA test
courses attendance. Only a small proportion of
midwives had HPV test courses. Colposcopy train-
ing were followed by 70.2% obstetrician.
In term of knowledge, all health workers knew
that HPV vaccination done as primary prevention
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of cervical cancer. A total of 98.3% of health work-
ers knew that the HPV vaccine is injected intramus-
cularly, 91.5% knew that HPV vaccination is given
3 times, ie at month 0, 1, 6 or 0, 2, 6, and 71.8%
knew that the HPV vaccine is injected in the del-
toid.
A total of 93.2% health workers knew that the
VIA test used for early detection of cervical cancer,
76.9% knew how to interpret the VIA test results
and 60.7% knew the steps of VIA test.
A total of 93.2% of health workers knew the
main purpose of Pap test and 82.1% knew the
steps of Pap test.
Most of the health workers (76.9%) knew that
HPV test is not routinely performed on women
aged less than 30 years old, 86.3% knew that HPV
test should be performed in women aged 30 years
or more, but only 36.8% knew the steps of HPV
test.
Table 1. Knowledge of Health Workers in Hospitals Jakarta in 2012 on Primary and Secondary Cervical Cancer Prevention.
Health workers have the right knowledge:
Type of health workers
Midwives GPs Obstetrician Total
n=49 % n=21 % n=47 % n=117 %
That HPV vaccination done as primary prevention of cervical cancer 49 100.0 21 100.0 47 100.0 117 100.0
That the HPV vaccine is injected intramuscularly 48 98.0 20 95.2 47 100.0 115 98.3
That HPV vaccination is given 3 times, ie at month 0, 1, 6 or 0, 2, 6 44 89.8 19 90.5 44 93.6 107 91.5
That the HPV vaccine is injected in deltoid 26 53.1 14 66.7 44 93.6 84 71.8
That VIA test is used for early detection of cervical cancer 49 100.0 20 95.2 47 100.0 116 99.1
That the VIA positive test results is apparently a white plaque on
the transformation zone
34 69.4 14 66.7 42 89.4 90 76.9
On VIA test steps 26 53.1 4 19.0 41 87.2 71 60.7
That the main objective of Pap test is the early detection of
cervical cancer
43 87.8 21 100.0 45 95.7 109 93.2
On Pap test steps 39 79.6 11 52.4 46 97.9 96 82.1
That HPV test is not routinely performed on women aged less
than 30 years
42 85.7 9 42.9 39 83.0 90 76.9
That HPV test should be performed in women aged 30 years or more 46 93.9 15 71.4 40 85.1 101 86.3
On HPV test steps 7 14.3 1 4.8 35 74.5 43 36.8
Table 2. Attitude of Health Workers in Hospitals Jakarta in 2012 on Primary and Secondary Cervical Cancer Prevention.
Health workers agreed that:
Type of health workers
Midwives GPs Obstetrician Total
n=49 % n=21 % n=47 % n=117 %
As health workers they should be able to perform a speculum
examination in women who are already married.
47 95.90 20 95.2 - - 73 95.7
All of the women aged 30-50 years who have had sexual
intercourse should be performed cervical cancer screening.
49 100.0 21 100.0 47 100.0 117 100.0
As health workers they could give HPV vaccination. 47 95.9 19 90.5 47 100.0 113 96.6
As health workers they could do VIA test. 45 91.8 19 90.5 46 97.9 110 94.0
As health workers they could do Pap test. 48 98 20 95.2 47 100.0 115 98.3
As health workers they could do HPV test. 42 85.7 20 95.2 45 95.7 107 91.5
As health workers they agreed to refer to obstetrician or
suggest colposcopy in cases of positive screening results.
49 100.0 21 100.0 - - 70 100.0
As obstetricians they can perform colposcopy. - - - - 47 100.0 47 100.0
As obstetrician will perform colposcopy examination in cases of
cervical cancer screening results indicate precancerous lesions.
- - - - 34 72.3 34 72.3
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In term of attitude, most of health workers
(95.7%) agreed that they should be able to perform
a speculum examination in women who are mar-
ried, and 100% agreed that all women aged 30-50
years who have had sexual intercourse should be
performed cervical cancer screening. The majority
of workers (96.6%) also agreed that they as health
workers could do HPV vaccination, 94% agreed to
conduct the VIA test, 98.3% agreed to do the Pap
test, and 91.5% agreed to do the HPV test.
All midwives and general practitioners agreed
that they would refer to obstetrician or suggest
colposcopy in cases of positive screening results.
All obstetrician agreed that they can do colposcopy,
and 72.3% agreed that they will perform colpos-
copy in cases of cervical cancer screening results
indicate precancerous lesions.
In terms of behavior, most of health workers
(76.9%) offered to the patient an HPV vaccination
and 62.4% given vaccination against HPV, 52.1%
offered and 30.8% did VIA test and 86.3% offered
and 71.8% performed Pap test. Only 45.3% and
25.7% of health workers offered and performed
HPV test respectively. The majority of female
health workers who fullfilled the requirements
(75%) already did Pap test for themselves, but only
5.4% had HPV test and only 32.5% of health work-
ers had received HPV vaccination.
The two most frequent reasons of the health
workers for not performing HPV vaccination for
themselves nor for their wives/mothers were their
feeling to have a low risk (32.0%) and no fund
(15.8%). While the two most frequent reasons for
not performing Pap test were also their feeling to
have a low risk (23.8%), and had no time (23.8%).
Regarding the reasons why health workers or their
wives/mothers did not perform HPV test, 18.1%
expressed a negative Pap test results and 16.9%
stated as low risk.
Regarding hospital facilities in Jakarta in the pre-
vention of cervical cancer, total of 20 (80%) of
Jakarta hospitals consist of 6 government and 14
private hospitals providing HPV vaccination. A type
C private hospital had the highest number in HPV
vaccine usage (40 vaccines per month). In terms of
providing promotion media for HPV vaccination,
only 11 hospitals in Jakarta that put up banners
HPV, 10 hospitals that provide HPV vaccination
leaflet in the obstetrician practice room, and 5 hos-
pitals that provide posters in the waiting room. A
total of 15 hospitals had given counseling about
HPV vaccination. Only 8 hospitals stated providing
discounts for HPV vaccination for their employees.
Only 11 from 25 hospitals surveyed provide VIA
test facility. The number of VIA test examination at
the hospital was unknown, because of no record.
In terms of VIA test publication, only 8 hospitals
provided a banner, 3 hospitals provided leaflets in
obstetrician practice room, 2 hospitals provided
poster in the waiting room and 9 hospitals did
counseling. Only 8 hospitals who claimed to give
discount/free for VIA tests for their employees, and
only 6 hospitals provide a discount/free for the
public.
Table 3. Health Workers’ Behavior in DKI Jakarta Hospitals in 2012 on Offering and Performing Primary and Secondary 
     Cervical Cancer Prevention to their Patients.
Subject as healthworker:
Type of health workers
Midwives General
Practitioner
Obstetrician Total
n=49 % n=21 % n=47 % n=117 %
Offering patients to perform HPV vaccination 39 79.6 18 85.7 33 70.2 90 76.9
Injecting the HPV vaccine to patients 27 55.1 7 33.3 39 83.0 73 62.4
Offering patients to conduct VIA test 24 49.0 8 38.1 29 61.7 61 52.1
Conducting VIA test to patients 12 24.5 2 9.5 22 46.8 36 30.8
Offering patients to perform Pap test 37 75.5 18 85.7 46 97.9 101 86.3
Conducting a Pap test to patients 33 67.3 5 23.8 46 97.9 84 71.8
Offering patients to conduct HPV test 17 34.7 8 38.1 28 59.6 53 45.3
Performing HPV test to patients 8 16.3 1 4.8 21 44.7 30 25.7
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All Jakarta hospitals that were surveyed pro-
vided Pap test. A total of 11 hospitals had Pap test
samples over than 30 monthly. A type C private
hospital had the highest sample of Pap test exami-
nation(130 samples per month). Only 11 hospitals
put up banners on Pap test, 3 hospitals provided
Pap test leaflet/poster in obstetrician practice
room, and 5 hospitals provided leaflet in the wait-
ing room. Eighteen hospitals claimed that they had
done a Pap test counseling. Only 12 hospitals gave
Pap test discounts for their employees, and only 6
that gave discounts for the public.
There are 7 hospitals provide thin-prep facility.
A type B private hospital had the highest number
of thin prep samples (50 samples per month). Only
1 hospital in Jakarta provide thin prep leaflets in
obstetrician practice room and 2 hospitals provide
thin-prep poster in the waiting room.
Only 6 hospitals provided HPV test, all of them
were private ones. A type B private hospital had
the highest samples of HPV test, which was 9 sam-
ples per month. Only 3 hospitals put up HPV test
banners, 7 hospitals had done HPV test counseling,
and 2 hospitals provided HPV test leaflets in obste-
trician practice room as well as in the waiting
room. No hospital provided discount on HPV test
for hospital employees, but there was 1 hospital
which gave discount for the public.
Ten hospitals, consists of two government and
8 private ones, provided colposcopy. There were
11 hospitals that had minimum one obstetrician
who already got courses on colposcopy. Only a
small number of obstetricians that worked in 8
hospitals admit that they had performed a colpos-
copy examination.
DISCUSSION
Most health professionals did not know the steps
of HPV test. This might be due to only a few
(35.9%) of them had attended HPV test course. It
might also be due to only a few hospitals (35%)
provide HPV test. In addition, the HPV test is rela-
tively new compared to Pap test, making it less
popular than the Pap test.1
Most health professionals had a good attitude
about cervical cancer prevention. All of them
agreed that all women aged 30-50 years who have
had sexual intercourse should have cervical cancer
screening. Previous study conducted on midwives
and general practitioners in primary health service
also acquired the same result, that is most mid-
wives and general practitioners agreed that every
married/sexually active woman should be perfor-
med speculum examination, and that general prac-
titioners and midwives should perform cervical
cancer screening.11
Many health workers did not perform VIA test
and HPV test to their patients. HPV DNA test re-
mains to be done despite the Pap test, because HPV
test is more sensitive than cytology in detecting NIS
2/3 (90% sensitivity), negative predictive value of
HPV test is very high (99%), specificity of the HPV
test is moderate (specificity 85%), the combination
of HPV DNA and cytology test will increase the sen-
sitivity of Pap test, from 50-85% into almost 100%
and the combination of HPV DNA test and cytology
for age> 30 years would be cost effective and it
does not require annual screening if both tests are
negative and there is not change in sexual part-
ner.12,13
Many health workers did not perform VIA test,
this might be due to the fact that only 11 hospitals
provide facilities for VIA test. Many health workers
did not do HPV test and this might be due to the
low level of HPV test knowledge; only 36.8% of
health workers knew the steps of HPV test. This
also might be due to HPV test facilities provided by
the hospitals, which is only 6 hospitals provide
HPV test, and the expensiveness of the test.
Many health workers did not perform HPV vac-
cination and HPV test, whether to themselves nor
their family (wives/mother). The two most com-
mon reasons for not getting HPV vaccination is the
belief that their risks are low (32%) and no funding
(15.8%). Ten midwives and 2 general practitioners
stated that they do not have the funding for HPV
vaccination. Based on the information obtained
from several hospitals and laboratories, it was re-
vealed that the cost of 1 HPV vaccination injection
ranged from Rp 750,000 to Rp 1,200,000, hence 3x
injections will cost Rp 2,200,000 to Rp 3,600,000,
while HPV test ranged from Rp 493,000 to Rp
900,000.
The two major reasons that HPV test was not
done was because of a negative Pap test results
(18.1%) and the belief of having a low risk
(16.9%).
Eventhough 80% of hospitals in Jakarta pro-
vided HPV vaccine, only 75% of that hospitals use
the vaccine. The lack of health promotion (by pos-
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ter/leaflet or counseling) of HPV vaccination pro-
vided by the hospitals could be the cause.
The high price of HPV vaccine could also affect
the lack of HPV vaccine usage in hospital and also
affect the availability of special (reduced) price in
the hospitals for the staff or community. The im-
munization coverage rate in the U.S. for adoles-
cents is lower than the coverage for vaccination in
children.
Only 49% of young women had HPV vaccination
in 2010. Obstacles to achieve vaccination coverage
are multifactorial, which include lack of knowledge
about vaccines and the diseases that can be pre-
vented by a vaccine, infrastructure issues, financial
issues, and the behavior of teenagers, parents and
providers to vaccination. Several studies have also
reported that the behavior of providers and pa-
rents can be modified to increase the public’s will-
ingness to vaccinate.14
HPV vaccination, although expensive, remains to
be done because HPV vaccination can prevent cer-
vical cancer when given to women who have not
been exposed to HPV15 virus so it can reduce cer-
vical cancer morbidity and mortality.
It is a concern to conduct cooperation among
government, world donor organizations, experts
and pharmaceutical professions for fascilitating
and providing more affordable HPV vaccine for
community.
Only a few hospitals in Jakarta provided VIA
and HPV tests, and fewer published the screening
methods, either in the form of the provision of leaf-
lets/posters, banner installation, or in conducting
counseling. In fact, information and education to
the community is important. It will make women
have the willingness to participate in screening
services, hence the objectives of cervical cancer
prevention program will be achieved. Providing in-
formation and education to the community should
be implemented in the community, health facilities,
and through various media. Network must be cre-
ated between health facilities and community.1
All hospitals in this survey provided Pap test.
There were 11 (44%) hospitals that have 30 Pap
test sample in a month. The availability of Pap test
facility, was one of the factor that contribute for
the successfulness of cervical cancer prevention.1
Only 40% hospitals in Jakarta provide colpos-
copy. In fact, colposcopy services should be avail-
able to evaluate suspicious invasive lesions.
The availability of trained staff, good equipment
and supply, are key factors for implementing effec-
tive cervical cancer prevention program.1
CONCLUSION
Most hospitals in Jakarta had health workers with
good knowledge and attitude on cervical cancer
prevention, but only a small percentage had a good
behavior on primary cervical cancer prevention.
Most hospitals in Jakarta provided HPV vaccina-
tion and Pap test, but most did not provide VIA,
HPV test, and colposcopy facilities. Further re-
search is needed to examine the cause of lack
good behavior in providing HPV vaccination. It is
important to implement complete facilities in the
hospital in Jakarta especially for VIA test and col-
poscopy facilities.
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